SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Exelixis, Inc. (EXEL)
An SI Board Since January 2001
Posts SubjectMarks Bans Symbol
930 66 0 EXEL
Emcee:  kinkblot Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
130The royalties from GSK are lower than you seem to think they are.DewDiligence_on_SI-2/17/2005
129No arguing that you were right 2.5 years ago and you enjoy pointing that out. Burkrw-2/17/2005
128EXEL has impressive science, but it is essentially a contract-research house forDewDiligence_on_SI-2/17/2005
127Exelixis Announces Fourth Quarter and Year-End 2004 Financial Results Wednesday nigel bates-2/16/2005
126(OT, MMP inhibitors) Apparently, something of the British Biotech (now part of nigel bates-2/16/2005
125USBPJ: Expect 3 more INDs in 2006. x647 P1 data potentially at '05 ASCO $keokalani'nui-1/27/2005
124ooops, wrong thread. Sorry, no post.scaram(o)uche-1/20/2005
123Ouch. It's really not fair to ask for bad jokes to be explained. Makes thenigel bates-1/20/2005
122I think that is funny, but have no idea why. Maybe this resignation is why Scankeokalani'nui-1/19/2005
121"So long, and thanks for all the fish" ?nigel bates-1/19/2005
120Simplest and most benign conclusion is Exelixis isn't going to be discoverinkeokalani'nui-1/19/2005
119Nope.scaram(o)uche-1/19/2005
118Are you aware of any background to this terse announcement? Thanks.tom pope-1/19/2005
117Item 5.02 Departure of Directors or Principal Officers; Election of Directors;scaram(o)uche-1/19/2005
116Snuck this one in at 9PM friday night: >>SOUTH SAN FRANCISCO, Calif., Jantuck-1/15/2005
115GS: EXEL(IL/N): Amended GSK agreement refines scope and accelerates funding 52-mopgcw-1/12/2005
114Just heard the call. It is better than I first thought. No matter if there is keokalani'nui-1/11/2005
113Analysts are more confused about the deal than I am. :-) rkrw-1/11/2005
112Fine. But if what really counts is the quality of the drug programs--and the cokeokalani'nui-1/10/2005
111The sheer difficulty in analyzing this change highlights what’s wrong with EXEL DewDiligence_on_SI-1/10/2005
110Here are my initial thoughts, which are at first blush negative--but without thekeokalani'nui-1/10/2005
109I think it means I wish I had more than a token amount of EXELtom pope-1/10/2005
108Want to take a stab at interpreting this? :-) Press Release Source: Exelixis,rkrw-1/10/2005
107Item 8.01 Other Events. On January 4, 2005, Exelixis, Inc. (the "Comscaram(o)uche-1/7/2005
106This is the one, baby. Previously guided IND for 1Q05. Hope they didn't keokalani'nui-12/16/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News